Author

Hans Heinrich Wedemeyer

Observed names: H Wedemeyer, H. Wedemeyer, H.H. Wedemeyer, Hans H Wedemeyer, Hans-Heinrich Wedemeyer, Wedemeyer, H.

Institution: Medizinische Hochschule Hannover

Observed institutions: Marche Polytechnic University, Hyogo Medical University, Inserm, German Cancer Research Center, King's College London, University of Milan, Instituto de Salud Carlos III, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Kyungpook National University, Osaka City University, Medizinische Hochschule Hannover, St. Josefs Hospital, German Center for Infection Research, Essen University Hospital, Helmholtz Centre for Infection Research, Center for HIV and Hepatogastroenterology, Institute for Interdisciplinary Medicine, Hospital Universitario de La Princesa, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, University Hospital Frankfurt, German Liver Foundation, Centre for Individualised Infection Medicine, King's College Hospital, Hôpital Paul-Brousse, Weill Cornell Medicine, ERN RARE-LIVER, Institut für Immunologie, Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa, The Ohio State University, Universidad Autónoma de Madrid, The University of Tokyo

OpenAlex ID: A5045533092

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

2024 · B. Sangro, S.L. Chan, et al. · Annals of Oncology · 365

Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals

2017 · Julia Dietz, Simone Susser, et al. · Gastroenterology · 147

Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients

2008 · S. Lovric, U. Erdbruegger, et al. · Nephrology Dialysis Transplantation · 85

O4 PROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-α-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDVRNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDY

2014 · H. Wedemeyer, C. Yurdaydin, et al. · Journal of Hepatology · 56

1419 a Randomized Trial Comparing Ribavirin Dose Reduction Versus Erythropoietin for Anemia Management in Previously Untreated Patients With Chronic Hepatitis C Receiving Boceprevir Plus Peginterferon/ribavirin

2012 · F.F. Poordad, E.J. Lawitz, et al. · Journal of Hepatology · 43

Early assessment of safety and efficacy of tropifexor, a potent non bile-acid FXR agonist, in patients with primary biliary cholangitis: An interim analysis of an ongoing phase 2 study

2018 · C. Schramm, G. Hirschfield, et al. · Journal of Hepatology · 28

410 Food Intake Increases Liver Stiffness in Patients With Chronic Hepatitis C Virus Infection

2009 · I. Mederacke, K. Wursthorn, et al. · Journal of Hepatology · 24

73 a Multicenter Analysis of Antiviral Response After One Year of Tenofovir Mono-therapy in Hbv-monoinfected Patients With Prior Nucleos(t)ide Analog Experience

2008 · F. van B¨ommel, R.A. de Man, et al. · Journal of Hepatology · 22

PDF

124 Impact of Pnpla3 (rs738409 C>g) Polymorphism on Fibrosis Progression and Steatosis in Chronic Hepatitis C

2011 · E. Trépo, P. Pradat, et al. · Journal of Hepatology · 18

Real-World Safety and Effectiveness of Ombitasvir/ Paritaprevir/R with Dasabuvir and/or Ribavirin in the German Hepatitis C Registry

2016 · H. Hinrichsen, H. Wedemeyer, et al. · Journal of Hepatology · 17

Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1–3 Infections

2019 · Julia Dietz, Ulrich Spengler, et al. · Clinical Gastroenterology and Hepatology · 13

PDF

Six Weeks of Sofosbuvir/Ledipasvir (SOF/LDV) are Sufficient to Treat Acute Hepatitis C Virus Genotype 1 Monoinfection: The Hepnet Acute HCV IV Study

2016 · K. Deterding, C. Spinner, et al. · Journal of Hepatology · 13

Strong intrahepatic decline of hepatitis D virus RNA and antigen after 24 weeks of treatment with Myrcludex B in combinationwith Tenofovir in chronic HBV/HDV infected patients: Interim results from a multicenter, open-label phase 2b clinical trial

2018 · L. Allweiss, C. Dettmer, et al. · Journal of Hepatology · 12

Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort

2015 · J. S. Doyle, K. Deterding, et al. · Journal of Viral Hepatitis · 12

366 Prevalence and Severity of Kidney Dysfunction in Patients With Chronic Hepatitis B in Europe: Data From the European Virgil Cohort

2011 · K. Deterding, N. Lampe, et al. · Journal of Hepatology · 12

61 Factors Influencing Progression of Liver Fibrosis in Patients With Chronic Hepatitis C: Results of the 3-year T2s-918-hcv Study With Hcve1 Therapeutic Vaccination

2008 · H. Wedemeyer, W. Mazur, et al. · Journal of Hepatology · 12

PDF

Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany

2013 · Jona T. Stahmeyer, Svenja Schauer, et al. · Journal of health economics and outcomes research · 11

PDF

Liver-first strategy for a combined lung and liver transplant in patients with cystic fibrosis

2021 · Khalil Aburahma, Jawad Salman, et al. · European Journal of Cardio-Thoracic Surgery · 9

217 Acoustic Radiation Force Imaging (arfi) as a New Method of Ultrasonographic Elastography Allows Accurate and Flexible Assessment of Liver Stiffness

2009 · K. Rifai, M.J. Bahr, et al. · Journal of Hepatology · 8

1012 Telbivudine-induced Hbeag Seroconversion in Chronic Hepatitis B (chb) Is Durable During 2 Years Off-treatment Follow-up

2010 · Y.-F. Liaw, K. Wursthorn, et al. · Journal of Hepatology · 7

Case Report: Convalescent Plasma Therapy Induced Anti-SARS-CoV-2 T Cell Expansion, NK Cell Maturation and Virus Clearance in a B Cell Deficient Patient After CD19 CAR T Cell Therapy

2021 · Berislav Bošnjak, Ivan Odak, et al. · Frontiers in Immunology · 6

PDF

Ledipasvir/Sofosbuvir Treatment for 8 Weeks in Treatment-Naïve HCV Genotype 1 Infected Patients under Real Life Conditions: Data from the German Hepatitis C-Registry (DHC-R)

2016 · P. Buggisch, K.H.W. Böker, et al. · Journal of Hepatology · 6

806 Management and Outcomes of Anemia in the International Telaprevir Early Access Program, for Patients With Hepatitis C Genotype 1 Infection

2013 · M. Colombo, I. Fernández, et al. · Journal of Hepatology · 6

Markers of cell death predict therapy response in patients with cirrhosis and hepatorenal syndrome

2022 · Sophia Heinrich, Thomas Austgen, et al. · United European Gastroenterology Journal · 5

Lb01 Six Weeks of Sofosbuvir/ledipasvir Treatment of Acute Hepatitis C Virus Genotype 1 Monoinfection: Final Results of the the German Hepnet Acute Hcv Iv Study

2016 · K. Deterding, C.D. Spinner, et al. · United European Gastroenterology Journal · 5

Works count: 116

Citation count: 998

H-index: 12

I10-index: 17